FOXO TECHNOLOGIES INC. Total Liabilities
FOXO TECHNOLOGIES INC. (FOXO) had Total Liabilities of $44.98 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities
us-gaap:Liabilities · last filed 2026-08-14
- 2026-06-30: Liabilities $44.98M.
- 2026-03-31: Liabilities $36.15M.
- 2025-12-31: Liabilities $33.50M.
- 2025-09-30: Liabilities $31.96M.
| Period end | Liabilities | Liabilities as first filed |
|---|---|---|
| 2026-06-30 | $44.98M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $36.15M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $33.50M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $31.96M 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $36.34M 10-Q · filed 2025-08-19 | |
| 2025-03-31 | $37.36M 10-Q/A · filed 2025-08-19 | $32.23M 10-Q · filed 2025-05-20 |
| 2024-12-31 | $36.44M 10-K · filed 2026-04-15 | |
| 2024-09-30 | $60.23M 10-Q · filed 2024-11-19 | |
| 2024-06-30 | $23.07M 10-Q · filed 2024-08-19 | |
| 2024-03-31 | $17.93M 10-Q · filed 2024-06-28 | |
| 2023-12-31 | $14.83M 10-K · filed 2025-04-15 | $14.82M 10-K · filed 2024-06-06 |
| 2023-09-30 | $14.23M 10-Q/A · filed 2024-06-04 | |
| 2023-06-30 | $11.08M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $9.90M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $28.70M 10-K · filed 2024-06-06 | |
| 2022-09-30 | $55.72M 10-Q · filed 2022-11-21 | |
| 2022-06-30 | $8.73M 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $12.35M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $55.52M 10-K · filed 2023-03-31 | $12.45M 10-K · filed 2022-03-07 |
| 2021-09-30 | $13.96M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $14.56M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $12.92M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $18.08M 10-K · filed 2022-03-07 | $7.07M 10-K · filed 2021-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |